Senores Pharmaceuticals signs agreement to acquire ANDAs from Teva Pharmaceuticals USA, Inc

13 Aug 2025 Evaluate

Senores Pharmaceuticals through its wholly-owned subsidiary -- Senores Pharmaceuticals, Inc., USA (SPI) has signed agreement to acquire two products of USFDA approved Abbreviated New Drug Applications (ANDAs) from Teva Pharmaceuticals USA, Inc. 

The acquisition will be funded through the Initial Public Offer (IPO) proceeds raised by the company. This is in line with the Objects of the IPO stated in the Red Herring Prospectus.

Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.

Senores Pharmaceutic Share Price

790.25 -12.50 (-1.56%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×